StockData
Eikon Therapeutics, Inc. logo

Eikon Therapeutics, Inc. (EIKN) stock

EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.98−0.06 (-0.99%)

Close on Nov 13, 2026Market cap $323.91MP/E –Yield –

Eikon Therapeutics statistics

38 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 29, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$323.91M
$272.32M
Enterprise Value
-$137.81M
$146.23M
PB Ratio
0.84
2.00
P/TBV Ratio
0.84
2.22

Share statisticsIndustry

Shares Change (QoQ)
0.06%
0.50%
Float
38M
49M
Shares Held by Insiders
29.4%
11.7%
Shares Held by Institutions
48.9%
56.4%

Short sellingIndustry

Short Interest
6M
–
Short Interest Change
-13.1%
-0.80%
Short % of Float
14.5%
9.01%
Short % of Shares Outstanding
10.2%
6.30%
Days to Cover
10.47
5.15

Stock price statisticsIndustry

20-Day Moving Average
$6.34
–
50-Day Moving Average
$7.53
–
Average True Range (14)
$0.67
–
Price Change (1 Week)
1.36%
-1.15%
Price Change (1 Month)
-20.7%
-4.87%
Price Change (3 Months)
-42.9%
-21.0%
Price Change (6 Months)
-54.9%
-20.6%
Average Volume (10 Days)
543,188
–
Average Volume (20 Days)
541,527
–
Average Volume (90 Days)
503,999
–
Relative Volume
0.58
0.70
Relative Strength Index (14)
42.9
43.4
Volatility (1 Year)
93.9%
80.1%

Financial positionIndustry

Current Ratio
7.21
3.30
Quick Ratio
6.97
2.39

EfficiencyIndustry

Employee Count
384
74

Balance sheetIndustry

Net Cash (Debt)
$461.72M
$17.76M
Net Cash Per Share
$8.52
$0.80
Equity (Book Value)
$384.29M
$53.89M
Book Value Per Share
$7.09
$1.50
Tangible Book Value
$384.29M
$27.13M
Working Capital
$411.85M
$79.99M

Scores and fair valueIndustry

Altman Z-Score
-1.03
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodEIKNS&P 500DifferenceEIKN per yearS&P 500 per year
1 month-11.0%-3.0%−8.0 pts
3 months-42.1%-2.8%−39.3 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M EIKN shares were sold short on Oct 30, 2026, down 13.1% from the previous report, or 14.49% of the shares available to trade. At recent volumes it would take 10.5 days to buy them back. Over the last 20 sessions, 54.6% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,536,871-13.1%528,96310.5
Oct 15, 20266,370,634+1.2%545,15211.7
Sep 30, 20266,294,602+15.4%716,0528.8
Sep 15, 20265,452,560+3.3%588,7969.3
Aug 31, 20265,280,850+26.3%512,72010.3
Aug 14, 20264,179,636-14.3%427,1879.8
Jul 31, 20264,875,396+5.4%244,28820.0
Jul 15, 20264,627,639-0.1%403,38711.5
Jun 30, 20264,631,532+2.8%584,2457.9
Jun 15, 20264,503,871+10.8%237,86818.9
May 29, 20264,065,276+12.6%392,91410.3
May 15, 20263,610,387+6.6%347,17210.4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?